Osteoarthritis And Muscle Wasting: What's The Connection?

can osteoarthritis cause muscle wasting

Osteoarthritis (OA) is a common joint disorder that results in degeneration and pain. Knee and hip OA are extremely prevalent, and their occurrence increases with ageing. OA is associated with muscle weakness and wasting, which can limit physical function and performance of daily activities. While the exact cause-and-effect relationship between OA and muscle wasting is not fully understood, research suggests that muscle wasting may directly affect joint stability and mobility, contributing to OA progression. This has led to a growing interest in exercise interventions and the regulation of microRNAs as potential treatments for OA.

Characteristics Values
Muscle wasting Occurs in patients with osteoarthritis
Type of osteoarthritis Knee osteoarthritis is the most common
Cause of osteoarthritis Degeneration of synovial joints
Symptoms Pain, disability, loss of independence, muscle weakness, stiffness, reduced joint range of motion
Treatment Pain management, total joint replacement, exercise interventions, strength training
Relationship between osteoarthritis and muscle wasting Not fully understood, but muscle wasting may affect joint stability and mobility
Role of microRNAs May regulate muscle mass and function, but the exact role is still under research

cyvigor

Knee osteoarthritis and muscle wasting

Osteoarthritis (OA) is a multifactorial condition associated with degeneration of the joint, with pathological changes to multiple musculoskeletal tissues such as cartilage, meniscus, ligaments, and synovium. Knee osteoarthritis is a leading cause of disability among older adults, and its incidence is expected to increase over the next two decades.

OA patients experience joint pain, stiffness, reduced joint range of motion, and muscle weakness. These deficits can limit the performance of daily activities and reduce quality of life. Knee OA, in particular, results in reduced functional capacity, which can be attributed to joint pain, stiffness, and loss of muscular strength of the lower extremity muscles.

Muscle impairments associated with knee OA affect physical function and should be targeted in therapy. Quadriceps muscle wasting is one of the muscle impairments observed in patients with knee OA. Muscle wasting directly affects the stability of the joints, and loss of mobility leads to gradual degeneration of articular cartilage. Exercise interventions can benefit OA patients by improving muscle tissues and joint tissues affected by OA. For example, low-impact exercises such as swimming and cycling have been shown to reduce pain and stiffness and improve functional deficits in patients with knee OA.

The molecular mechanisms underlying muscle wasting in OA are not well understood, but studies have focused on inflammatory mediators as the molecular link between muscle function and OA. For instance, increased inflammation was observed in the vastus lateralis in patients with knee OA compared to a control group. Results from another study showed significant pathogenic fibrosis in the muscle of OA patients, along with aberrant collagen deposition in the extracellular matrix of OA muscle, which was associated with decreased satellite cell density and muscle strength.

cyvigor

Hip osteoarthritis and muscle wasting

Osteoarthritis (OA) is a debilitating disease that causes chronic disability in adults, resulting in degeneration and pain in the synovial joints. Knee and hip OA are common types of OA that become more prevalent with ageing. Hip OA patients often experience joint pain, stiffness, reduced joint range of motion, and muscle weakness, which can significantly impact their daily activities and quality of life.

Muscle wasting, or sarcopenia, is a condition characterised by a loss of muscle mass and function. It is commonly associated with ageing and can lead to joint instability and mobility issues. While the exact molecular mechanisms underlying muscle wasting in OA are not yet fully understood, research suggests that it plays a crucial role in the development and progression of OA. Studies have shown that individuals with mild-to-moderate hip OA exhibit lower limb muscle strength and volume deficits, indicating muscle wasting in the affected limb.

The link between muscle wasting and OA is a subject of ongoing research. Some studies suggest that muscle wasting directly affects joint stability and mobility, contributing to the gradual degeneration of articular cartilage in OA. Additionally, microRNAs have emerged as potential therapeutic targets for regulating muscle mass and function in OA. However, the role of microRNAs in muscle wasting during OA requires further investigation.

Currently, there is no cure for hip OA, and the disease often progresses to more advanced stages. Clinical guidelines recommend strength training as an intervention to manage hip OA and prevent the development of muscle weakness and strength asymmetries associated with advanced hip OA. Early interventions targeting muscle weakness can help improve patients' quality of life and delay the progression of the disease.

cyvigor

The role of inflammation

Osteoarthritis (OA) is a joint disorder resulting in degeneration of synovial joints, causing pain, disability, and loss of independence. Knee and hip OA are the most common types, with occurrence increasing as people age. OA is characterised by degradation of articular cartilage, subchondral bone sclerosis, osteophyte formation at the joint margin, and synovitis.

Synovial inflammation (synovitis) is present during all stages of OA, with inflammation observed even before cartilage degeneration. OA patients and rodent models of OA exhibit changes in cartilage, meniscus, synovium, and ligament, indicating common mechanisms of joint degeneration during OA development.

On the other hand, it has been suggested that disuse of an OA-affected joint due to pain and reduced mobility may be the primary cause of muscle wasting in OA patients. This is supported by studies showing that muscle strengthening interventions can relieve pain and improve physical function and structural changes in OA patients.

Further research is needed to fully understand the complex interaction between inflammatory signalling and muscle mass loss in OA patients. Longitudinal studies that consider confounders such as age, disease severity, and physical activity levels will help improve our understanding and contribute to the development of effective therapeutic strategies to combat muscle wasting in OA.

cyvigor

Exercise interventions

Osteoarthritis (OA) is a joint disorder resulting in degeneration of synovial joints, causing pain, disability, and loss of independence. While the impact of muscle wasting on OA progression is not fully understood, muscle wasting is believed to affect joint stability and mobility, leading to articular cartilage degeneration. Exercise interventions are crucial in managing OA and preventing further deterioration.

For patients with upper limb OA, the focus should be on improving the affected joints' range of motion and flexibility. In contrast, lower limb OA patients should concentrate on enhancing muscle strength and body stability. Individualized exercise prescriptions are essential, considering the degree of lesion and patients' needs.

Aerobic exercise is an effective training method to alleviate pain and improve body function. Low-intensity aerobic exercise is more beneficial for patients with severe OA, while high-intensity aerobic exercise helps those with mild OA. Strength training is particularly useful in improving muscle strength, and neuromuscular training is ideal for relieving OA pain.

Additionally, early intervention with swimming can alleviate knee joint stiffness and is more effective than land exercises. Therapeutic exercise following joint distraction can also inhibit muscle wasting and delay the progression of post-traumatic OA, as seen in rabbit studies. Overall, exercise interventions play a vital role in managing OA symptoms and improving patients' quality of life.

cyvigor

Molecular mechanisms

Osteoarthritis (OA) is regarded as a disease of the articular cartilage, however, recent research has demonstrated alterations in the periarticular muscles that surround the affected joint. OA is the most prevalent joint disease causing disability, and the knee is the most commonly affected joint.

OA patients experience reduced functional capacity, which can be attributed to joint pain, stiffness, and loss of muscular strength of the lower extremity muscles. Quadriceps, hamstrings, and hip muscles are significantly impaired in subjects with knee OA compared with age-matched controls. Muscle strength, especially quadriceps, is a major determinant of both performance-based and self-reported physical function.

Studies exploring the molecular mechanisms underlying muscle wasting in OA have mostly focused on inflammatory mediators as the molecular link between muscle function and OA. Levinger et al. observed increased inflammation in the vastus lateralis in patients with knee OA compared to a control group, based on increased protein abundance of p65 NF-κB, STAT-3, and JNK. Another study found increased levels of inflammatory mediators including monocyte chemoattractant protein-1 (MCP-1) in the muscles of patients with knee OA.

In an animal model of OA induced by anterior cruciate ligament transection (ACLT), gastrocnemius muscle wasting coincided with elevated expression of interleukin (IL)-1β within the muscle. ACLT-induced OA also promoted tibialis anterior (TA) muscle wasting, in a manner associated with inflammatory signs. The increased levels of IL-1β and myostatin and the decreased levels of myogenin in the gastrocnemius muscle of OA animals may partially explain the mechanisms involved in this atrophy.

Other pathways involved in muscle wasting include reduction of protein synthesis, increased proteolysis, and impaired muscle regeneration. Markers of these pathways include myogenin, MyoD, myostatin, and MuRF-1. Pax7 is a biomarker specifically expressed in all quiescent satellite cells, which are involved in muscle regeneration. MyoD and myogenin are markers of satellite cell proliferation and differentiation, respectively.

Exercise following joint distraction has been shown to inhibit muscle wasting and delay the progression of post-traumatic osteoarthritis in rabbits by activating PGC-1α in skeletal muscle.

Frequently asked questions

Osteoarthritis (OA) is a degenerative joint disorder that can lead to pain, disability and loss of independence. While it is primarily regarded as a disease of articular cartilage degeneration, recent studies have shown that OA also causes alterations in the periarticular muscles surrounding the affected joint. This includes muscle weakness and wasting, particularly in the lower limb muscles for those with hip OA and the quadriceps for those with knee OA.

Symptoms of osteoarthritis include joint pain, stiffness, reduced range of motion, and muscle weakness. It is the most common form of arthritis, affecting synovial joints and causing disability, particularly in older adults.

The exact mechanism of muscle wasting in OA is not fully understood, but it is believed to involve changes in gene expression and epigenetic modifications. Studies have also found increased levels of inflammatory mediators, suggesting that muscle atrophy accelerates the degenerative process in the joint.

While there is no cure for OA, strength training and exercise interventions have been recommended to manage the condition and improve muscle strength. Additionally, novel treatments such as microRNA-based therapies are being explored to regulate muscle mass and function.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment